Acumen Pharmaceuticals, Inc. Earnings Per Share, Basic and Diluted
Acumen Pharmaceuticals, Inc. (ABOS) reported Earnings Per Share, Basic and Diluted of -$0.23 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-16
- Acumen Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.23.
- Acumen Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.21.
- Acumen Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.10.
- Acumen Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$141.93.
- Acumen Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2021 was -$5.02.
- Acumen Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2020 was -$17.48.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.23 10-Q · filed 2022-05-16 | -$0.43 derived: net income ÷ weighted average shares · filed 2023-05-09 | -$0.54 derived: net income ÷ weighted average shares · filed 2023-05-09 | -$2.76 derived: net income ÷ weighted average shares · filed 2023-05-09 |
| 2021-12-31 | -$0.21 derived: net income ÷ weighted average shares · filed 2023-03-27 | -$0.31 derived: net income ÷ weighted average shares · filed 2023-03-27 | -$2.78 derived: net income ÷ weighted average shares · filed 2023-03-27 | -$5.02 10-K · filed 2022-03-28 |
| 2021-09-30 | -$0.10 10-Q · filed 2021-11-15 | -$3.37 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$7.00 10-Q · filed 2021-11-15 | -$9.41 derived: net income ÷ weighted average shares · filed 2022-11-14 |
| 2021-06-30 | -$141.93 10-Q · filed 2021-08-16 | -$207.52 10-Q · filed 2021-08-16 | -$210.40 derived: net income ÷ weighted average shares · filed 2022-08-15 | -$216.84 derived: net income ÷ weighted average shares · filed 2022-08-15 |
| 2021-03-31 | -$64.41 10-Q · filed 2022-05-16 | -$66.21 derived: net income ÷ weighted average shares · filed 2022-05-16 | -$72.16 derived: net income ÷ weighted average shares · filed 2022-05-16 | -$77.01 derived: net income ÷ weighted average shares · filed 2022-05-16 |
| 2020-12-31 | -$1.80 derived: net income ÷ weighted average shares · filed 2022-03-28 | -$7.74 derived: net income ÷ weighted average shares · filed 2022-03-28 | -$12.60 derived: net income ÷ weighted average shares · filed 2022-03-28 | -$17.48 10-K · filed 2022-03-28 |
| 2020-09-30 | -$5.94 10-Q · filed 2021-11-15 | -$10.80 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$15.68 10-Q · filed 2021-11-15 | |
| 2020-06-30 | -$4.86 10-Q · filed 2021-08-16 | -$9.73 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |